• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The natural history of colorectal cancer. Opportunities for intervention.

作者信息

Winawer S J, Zauber A G, Stewart E, O'Brien M J

机构信息

Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.

出版信息

Cancer. 1991 Feb 15;67(4 Suppl):1143-9. doi: 10.1002/1097-0142(19910215)67:4+<1143::aid-cncr2820671507>3.0.co;2-d.

DOI:10.1002/1097-0142(19910215)67:4+<1143::aid-cncr2820671507>3.0.co;2-d
PMID:1991272
Abstract

There is now a better understanding of the natural history of colorectal cancer, which has provided a basis for intervention to influence outcome. The possible interventions include earlier detection of colorectal cancer, removal of premalignant adenomas, demonstration of the mucosal field defect that precedes neoplasia to evaluate baseline risk and its change with dietary modification, and identification of inherited and dietary risk factors. Five controlled trials evaluating early detection of colorectal cancer with fecal occult blood testing have enrolled more than 309,000 patients. Early stage cancers with improved survival has been observed, but data on mortality reduction have not as yet been reported. Studies of patients with adenomas have demonstrated high synchronous and metachronous rates as a basis for complete colon evaluation initially and a surveillance follow-up program. Hyperproliferation and lack of normal differentiation have been observed as a field defect in the colon preceding neoplasia. Inherited factors have recently been shown to be important in a larger proportion of individuals destined to develop colorectal adenomas and cancer. These observations of the natural history of colorectal cancer have provided new opportunities for the application of radiologic and endoscopic techniques in diagnosis and surveillance; each examination has its merit. Further research is needed to answer many critical questions that have been raised regarding the impact of these interventions.

摘要

相似文献

1
The natural history of colorectal cancer. Opportunities for intervention.
Cancer. 1991 Feb 15;67(4 Suppl):1143-9. doi: 10.1002/1097-0142(19910215)67:4+<1143::aid-cncr2820671507>3.0.co;2-d.
2
Aspects of the Natural History of Sessile Serrated Adenomas/Polyps: Risk Indicators for Carcinogenesis in the Colorectal Mucosa?无蒂锯齿状腺瘤/息肉的自然史特征:结直肠黏膜癌变的风险指标?
Dis Colon Rectum. 2018 Dec;61(12):1380-1385. doi: 10.1097/DCR.0000000000001208.
3
Incidence and risk factors of metachronous colorectal neoplasm after curative resection of colorectal cancer in Korean patients.韩国患者结直肠癌根治术后异时性结直肠肿瘤的发生率及相关危险因素分析。
J Dig Dis. 2014 Jul;15(7):367-76. doi: 10.1111/1751-2980.12154.
4
Risk and surveillance of individuals with colorectal polyps. Who Collaborating Centre for the Prevention of Colorectal Cancer.结直肠息肉患者的风险与监测。世界卫生组织结直肠癌预防协作中心
Bull World Health Organ. 1990;68(6):789-95.
5
6
National Polyp Study data: evidence for regression of adenomas.国家息肉研究数据:腺瘤消退的证据
Int J Cancer. 2004 Sep 10;111(4):633-9. doi: 10.1002/ijc.20277.
7
Risk factors for metachronous adenoma in the residual colon of patients undergoing curative surgery for colorectal cancer.接受结直肠癌根治性手术患者残留结肠中异时性腺瘤的危险因素。
Int J Colorectal Dis. 2017 Nov;32(11):1609-1616. doi: 10.1007/s00384-017-2881-x. Epub 2017 Aug 21.
8
Advanced synchronous adenoma but not simple adenoma predicts the future development of metachronous neoplasia in patients with resected colorectal cancer.高级别同步腺瘤而非单纯性腺瘤可预测结直肠癌切除术后患者异时性肿瘤的未来发展。
J Clin Gastroenterol. 2010 Aug;44(7):495-501. doi: 10.1097/MCG.0b013e3181d6bd70.
9
Colonoscopy: a review of its yield for cancers and adenomas by indication.结肠镜检查:按适应证对其癌症和腺瘤检出率的综述。
Am J Gastroenterol. 1995 Mar;90(3):353-65.
10
The effect of small or diminutive adenomas at baseline colonoscopy on the risk of developing metachronous advanced colorectal neoplasia: KASID multicenter study.基线结肠镜检查中小或微小腺瘤对发生结肠直肠腺瘤性息肉进展的风险的影响:KASID 多中心研究。
Dig Liver Dis. 2018 Aug;50(8):847-852. doi: 10.1016/j.dld.2018.04.001. Epub 2018 Apr 11.

引用本文的文献

1
Competition in Colon Cancer Screening? What Is the Role of Colonoscopy?结肠癌筛查中的竞争?结肠镜检查的作用是什么?
Viszeralmedizin. 2014 Feb;30(1):18-25. doi: 10.1159/000358445.
2
Development and validation of a clinical score for predicting risk of adenoma at screening colonoscopy.用于预测结肠镜筛查时腺瘤风险的临床评分的开发与验证
Cancer Epidemiol Biomarkers Prev. 2015 Jun;24(6):913-20. doi: 10.1158/1055-9965.EPI-14-1321. Epub 2015 Mar 23.
3
CYP1A1, GSTM1, GSTT1 and NQO1 polymorphisms and colorectal adenomas in Japanese men.
CYP1A1、GSTM1、GSTT1 和 NQO1 多态性与日本男性结直肠腺瘤的关系。
World J Gastroenterol. 2013 Jul 7;19(25):4023-30. doi: 10.3748/wjg.v19.i25.4023.
4
Effect of comorbid conditions on adherence to colorectal cancer screening.共病情况对结直肠癌筛查依从性的影响。
J Cancer Educ. 2012 Jun;27(2):269-76. doi: 10.1007/s13187-011-0303-2.
5
Circulating vitamin D and colorectal adenomas in Japanese men.循环维生素 D 与日本男性结直肠腺瘤。
Cancer Sci. 2010 Jul;101(7):1695-700. doi: 10.1111/j.1349-7006.2010.01575.x. Epub 2010 Mar 23.
6
Colorectal cancer screening.结直肠癌筛查。
Curr Oncol Rep. 2009 Nov;11(6):482-9. doi: 10.1007/s11912-009-0065-8.
7
C-reactive protein and colorectal adenomas: Self Defense Forces Health Study.C反应蛋白与结直肠腺瘤:自卫队健康研究
Cancer Sci. 2009 Apr;100(4):709-14. doi: 10.1111/j.1349-7006.2009.01107.x.
8
Expression of 17-1A antigen and complement resistance factors CD55 and CD59 on liver metastasis in colorectal cancer.17-1A抗原及补体抵抗因子CD55和CD59在结直肠癌肝转移灶中的表达
J Gastrointest Surg. 2001 Nov-Dec;5(6):673-9. doi: 10.1016/s1091-255x(01)80111-6.
9
Comparison of p53 and bcl-2 expression in initial, synchronous, and metachronous colorectal adenomas.
Surg Today. 1999;29(8):707-12. doi: 10.1007/BF02482313.
10
Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer.纤溶酶原激活剂及其抑制剂对杜克B期和C期结直肠癌患者生存预后的影响
Br J Cancer. 1997;75(12):1793-801. doi: 10.1038/bjc.1997.306.